The 2026 Australian Menopause Experience Report
The 2026 Australian Menopause Experience Report
The Menopause Stage Gap
New UMA40 data from 1,468 women shows menopause is not a single midlife moment, but a multi-stage health transition affecting cognition, energy, sleep, relationships, work and emotional wellbeing. Stage, not age alone, is emerging as the clearest guide to what women need.
Dr Nicole Avard
GP, Metluma
“In clinical practice, many women present assuming they are stressed, burnt out or simply ageing badly. What often sits underneath that is an unmanaged menopause transition. By the time they seek help, symptoms are frequently multi- layered, affecting sleep, cognition, mood, libido and quality of life all at once.”
“What this report reinforces is that menopause cannot be reduced to hot flushes or a single age bracket. Women need nuanced, stage-aware care that looks at the whole person. When symptoms are identified early and tracked properly, whole of life (health, home, employment) outcomes can improve significantly.”
What we found
women completed UMA40 since launch in March 2025.
0
Nearly 1 in 4
are under 44.
presented with moderate-to-severe overall symptom load.
0
%
triggered a clinical “red-flag” meaning they were at severe risk.
0
%
reported moderate-or-above fatigue.
0
%
want cognitive clarity.
0
%
of symptoms varied significantly by menopause stage.
0
%
of Metluma program progress-review participants improved overall symptom load and 78% showed improvement in MenoD score.
0
%
What the data is telling us
What this means for women’s health
Women’s menopause experiences are not linear, age-bound or limited to hot flushes. UMA40 shows a broad symptom burden across physical, cognitive, psychological, sleep and relational domains.
If care is guided by age alone, women are likely to be missed, misdirected or told symptoms are “just stress”. That creates clinical, workplace, relationship and mental health risk.
Support must be early, personalised and continuous, with stage-based assessment, symptom tracking and care pathways that address function, not just symptom control.
We cannot continue to see half of women presenting with moderate-to-severe overall symptoms and triggering “red flags” of clinical significance.
